Introduction {#S0001}
============

As nanotechnology is taking an increasing attention in fabrication of nanomaterial-based compounds for protein[@CIT0001] and cell delivery agents,[@CIT0002] revealing the impact of the physicochemical properties of nanoparticles (NPs) such as their chemical composition on the protein structures and cells viability has become critically necessary[@CIT0003] Based on the unique properties of silica (SiO~2~) NPs, they offer potential stem cell delivery[@CIT0004],[@CIT0005] and protein delivery[@CIT0006],[@CIT0007] applications. Hence, synthesis and development of novel SiO~2~-based multipotent carriers might be productive in the treatment of a wide range of diseases in vivo. However, before clinical applications of SiO~2~ NPs, their adverse effects should be examined against biological systems, such as proteins and cells in vitro. Actually, it may be indicated that NPs may induce some irreversible effects on the protein structure and cell viability[@CIT0008] For example, it has been well documented that the interaction of iron NPs with BSA is spontaneous, causing some changes in the secondary structure of the protein[@CIT0009] Data obtained from interaction of human hemoglobin with nanodiamond indicated that the hydrophobic interactions between nanodiamond and hemoglobin result in the significant secondary structural alteration of hemoglobin[@CIT0010] Morever, it was specified that bare or functionalized titanium dioxide (TiO~2~) NPs may induce different effects on the protein structure[@CIT0011] It was also reported that composite NP like TiO~2~/tungsten trioxide/graphene oxide can induce activity changes of catalase (CAT) and superoxide dismutase[@CIT0012] Nonetheless, it was revealed that the electrostatic interaction between zinc oxide NPs and BSA results in the slight quaternary structural changes of the protein and the secondary structure of BSA retained its identity[@CIT0013] Therefore, based on the type of NPs or the physicochemical characteristics of NPs, their kind of interaction and corresponding induced structural changes of the protein may provide different outcomes. Regarding cellular effects of NPs, some conflicting results have been also depicted. For example, the cytotoxicity effects of silver NPs,[@CIT0014] zinc oxide doped TiO~2~ nanocrystals[@CIT0015] and bismuth oxide NPs[@CIT0016] against human lung epithelial cells, human lung epithelial cells (A549) and human breast cancer (MCF-7) cells have been reported, respectively. But, it has been determined that some nanomaterials like iron NPs can serve as efficient and safe agents for internalization in the cells[@CIT0017] In this regard, conflicting data have encouraged scientists to study the interaction of NPs with proteins and cells to explore the scenario behind the toxicity of NPs against biological systems. Meanwhile, to study the biological effects of SiO~2~ NPs on protein structure, human erythrocyte CAT was chosen as the target macromolecule. CAT has a tetrameric structure with dominant α-helix conformation and it protects the cells against hydrogen peroxide[@CIT0018] As a consequence, any conformational changes of CAT result in its deactivation and elevation of oxidative stress accompanied by cell death. In this study, CAT interaction with SiO~2~ NPs was explored by spectroscopic and theoretical approaches.

Human mesenchymal stem cells (hMSCs) were also used to detect the cytotoxicity of SiO~2~ NPs against normal cells. MSCs-based therapies have shown potential applications in preclinical and clinical cases for treating a wide range of disorders.[@CIT0019],[@CIT0020] NPs can be used to increase MSCs therapeutic efficacy for several disorders.[@CIT0021],[@CIT0022] However, before the application of NPs as manipulating agents for MSCs differentiation,[@CIT0021] cytotoxicity of NPs like SiO~2~ NPs as a function of viability and apoptosis should be explored to determine their biocompatibility. Also, it has been well documented that MSCs can be used as a potential cellular model for examining the cytotoxicity of engineered NPs[@CIT0023] Consequently, hMSCs were also used to detect the cytotoxicity of SiO~2~ NPs.

Materials and methods {#S0002}
=====================

Material {#S0002-S2001}
--------

Alpha-minimum essential medium (α-MEM), FBS, L-glutamine, streptomycin and penicillin were purchased from Sigma-Aldrich Co. All other materials were of analytical grade.

Methods {#S0002-S2002}
-------

### Fluorescence study {#S0002-S2002-S3001}

CAT sample with a concentration of 2 µM was titrated with different concentrations of SiO~2~ NPs (1, 5, 10, 15 and 20 µM) at 298, 310 and 315 K. Samples were then exited at 280 nm and emission was read at 340 nm using a Cary Eclipse VARIAN fluorescence spectrophotometer. The excitation and emission slits were fixed at 5 and 10 nm, respectively. The phosphate buffer (pH 7.4, 20 mM) was used throughout the study. The fluorescence signal from the protein in the presence of NPs was subtracted from the fluorescence intensity of NPs and corrected for inner filter effect. In all experiments, CAT fluorescence intensity was measured in triplicate and the mean of the three data is reported.

### Circular dichroism (CD) study {#S0002-S2002-S3002}

The CD signal of CAT with a concentration of 5 µM in the absence and presence of SiO~2~ NPs (5, 10, and 20 µM) was recorded by employing an AVIV 215 spectropolarimeter (Aviv Associates, Lakewood, NJ, USA). Ellipticity change (*θ*) of the protein in the wavelength range 190--260 nm was reported as the NPs concentration was increased from 5 to 20 µM. The experiment was performed at room temperature and the NPs and proteins were dissolved in the phosphate buffer solution (pH 7.4, 20 mM). The CD spectrum of CAT in the presence of NPs was subtracted from the spectra of NPs and buffer.

### CAT assay {#S0002-S2002-S3003}

CAT activity was assayed based on the rate of H~2~O~2~ decomposition as determined by the reduction of absorbance at 240 nm. The reaction mixture contained 970 µL phosphate buffer (pH 7.4, 50 mM), 10 µL of 1--20 mM H~2~O~2~ (3%), 10 µL of 0.025 mg/mL CAT and 10 µL of 10--50 µM of SiO~2~ NPs. The experiment was done at room temperature and the data was reported as the average of three independent experiments.

### Molecular docking and dynamics {#S0002-S2002-S3004}

(SiO~2~)~72~ cluster was designed and used as a model of SiO~2~ NPs. This model was constructed by Cartesian coordinates of atoms obtained from Munde et al[@CIT0024] and Sabziparvar et al[@CIT0025] studies. In order to compare the effect of silica and silicon clusters, a Si~20~ cluster as a model of silicon NPs was designed using the Gaussian 98W suite of program.[@CIT0025],[@CIT0026] The B3LYP functional with the 6-31G(d) basis set was used to study the interaction of clusters with CAT. HEX 6.3 software as a molecular docking program was used to calculate and display attainable docking modes of CAT and NP clusters[@CIT0027] A spherical cluster of SiO~2~ NPs with a diameter of 30 Å was constructed by repeating its unit cell for the simulation study. The molecular dynamic simulations were performed using Forcite code and universal force field[@CIT0028]

### Cell culture {#S0002-S2002-S3005}

hMSCs derived from bone marrow were purchased from Royan Institute of Tehran, Iran. The extraction and purification of these cells were performed under Ethical Procedures approved by Ethical Committee of Royn Institute. The characterization of extracted cells based on surface marker expression was previously reported[@CIT0029] Cells were cultured in α-MEM medium containing FBS (10%, v/v), L-glutamine (0.3 mg/mL), streptomycin (100 μg/mL) and penicillin (100 U/mL) and kept at 37°C in a 5% CO~2~. When hMSCs reached sub-conﬂuence after five passages and after separation of non-adherent cells, varying concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) were added to the cell culture medium for 24 hrs.

### Cell viability analysis {#S0002-S2002-S3006}

The viability percent of hMSCs in the presence of varying concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) was analyzed using the MTT assay. Brieﬂy, after treatment of cells for 24 hrs, 10 µL MTT with a concentration of 5 mg/mL was added to each well for 2 hrs. Then, the supernatant was gently removed and the formazone crystals were dissolved in 100 µL DMSO. Finally, the absorbance intensity was measured at 570 nm using an ELISA reader (Expert 96, Asys Hitch, Ec Austria). The cell viability percent was presented against the control samples.

### Cellular uptake of SiO~2~ NPs {#S0002-S2002-S3007}

The uptake of SiO~2~ NPs was explored by flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA, USA) based on our previous paper[@CIT0030]

### Cell morphology assay {#S0002-S2002-S3008}

The cell morphology incubated with increasing concentrations of SiO~2~ NPs (10, 50, 100 and 200 µg/mL) for 24 hrs was observed employing invert microspore (Ziess, Germany).

### Lactate dehydrogenase (LDH) assay {#S0002-S2002-S3009}

The cytotoxicity of SiO~2~ NPs against hMSCs was determined using a LDH assay kit (Colorimetric, ab102526) based on the manufacturer's protocol. Briefly, cells were cultured, treated with increasing concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) for 34 hrs, collected and incubated with reaction mixture. The output was read immediately at OD 450 nm to measure the LDH activity as a percentage of the control.

### Intracellular determination of ROS {#S0002-S2002-S3010}

The generation of reactive oxygen radicals was analyzed using 2′,7′-dichloroﬂuorescein diacetate \[(DCFDA)/H~2~DCFDA -- cellular ROS assay kit (ab113851)\]. The DCF ﬂuorescence intensity is extensively correlated with the generation of intracellular reactive oxygen species. Briefly, the cells were treated with different concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL), collected in tubes, stained with DCFDA and incubated at 37°C for 30 min. Afterward, the ﬂuorescence intensity (λ~ex~=495 nm, λ~em~=529 nm) of solution was analyzed using FACScan cytometer (FACSCalibur; Becton-Dickinson, San Jose, CA, USA).

### Caspase-3 activity assay {#S0002-S2002-S3011}

The assay of caspase-3 enzyme was carried out in cells treated with various concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) using a commercially available kit (Caspase-3 assay kit \[Colorimetric, ab39401\]). Brieﬂy, the control and the SiO~2~ NPs-treated cells were harvested after treatment for 24 hrs and re-suspended in 50 µL of chilled lysis buffer for 10 mins followed by centrifugation at 10,000 g for 5 mins. Protein concentration was then determined by Bradford assay and BSA was used as a standard. Supernatants were then incubated with caspase-3 substrate (N-acetyl-DEVD-p-nitroaniline) at 37°C for 2 hrs and absorbance intensity was analyzed at 405 nm, using a microplate reader (Expert 96, Asys Hitch, Ec Austria).

### Flow cytometry analysis {#S0002-S2002-S3012}

Apoptosis quantification was done based on the manufacturer protocol of Annexin V-FITC Apoptosis Staining/Detection Kit (ab14085). Briefly, after treatment with 200 µg/mL of SiO~2~ NPs for 24 hrs, hMSC (1×10^6^) cells were collected by centrifugation, re-suspended, combined with 500 µL of 1X Annexin V binding buffer, mixed with 5 µL of Annexin V-FITC and 5 µL propidium iodide (PI), and incubated at room temperature for 5 mins in the dark. Finally, the cells were analyzed by FACScan cytometer (FACSCalibur; Becton-Dickinson, San Jose, CA, USA).

### Statistical analysis {#S0002-S2002-S3013}

Statistical analyses were performed using the SPSS software. Data were expressed as mean±SD of three independent experiments. One-way ANOVA and Student's *t*-test were done to determine statistical signiﬁcance. Differences between groups were considered to be signiﬁcant at *P*\<0.05.

Results {#S0003}
=======

Synthesis and characterization of SiO~2~ NPs {#S0003-S2001}
--------------------------------------------

SiO~2~ NPs with a size of about 20 nm were fabricated in our previous study by sol--gel method and were characterized by different approaches[@CIT0031]

Quenching mechanism {#S0003-S2002}
-------------------

CAT sample was titrated by different doses of SiO~2~ NPs at 298, 310 and 315 K and plots of fluorescence quenching are displayed in [Figure 1](#F0001){ref-type="fig"}. It can be deduced that quenching efficacy is varied by temperature. To quantify the impact of temperature and identify the quenching mechanism, the Stern--Volmer [Equation (1)](#M0001) was plotted[@CIT0032] $$\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${F_o}/F = {K_{SV}}\left[{{\rm{Si}}{{\rm{O}}_{\rm{2}}}\,{\rm{NP}}} \right] + {\ }1{\ } = {k_q}\tau o\left[{{\rm{Si}}{{\rm{O}}_{\rm{2}}}\,{\rm{NP}}} \right]{\ } + {\ }1$$
\end{document}$$Figure 1Fluorescence quenching of CAT in the presence of different concentrations of SiO~2~ NPs: 0 (red), 1 (blue), 5 (purple), 10 (grey), 15 (yellow) and 20 μM (green) at 298 (**A**), 310 (**B**) and 315 K (**C**).

where *F~o~, F, K~SV~, k~q~* and *τo* represent the fluorescence in the absence of ligand, fluorescence in the presence of ligand, Stern--Volmer constant, CAT quenching rate and lifetime of CAT fluorescence without ligand, respectively.

It was seen that the *K~SV~* values were 4.1±0.76×10^4^, 4.3±0.064×10^4^ and 5.0±0.61×10^4^ M^−1^ at 298, 310 and 315 K, respectively ([Figure 2](#F0002){ref-type="fig"}, [Table 1](#T0001){ref-type="table"}). Thus, as the *K~SV~* value increases by the elevation of temperature, a dynamic quenching system may be involved in the quenching mechanism of CAT by SiO~2~ NPs[@CIT0032] Nevertheless, the *kq* value was in the order of 10^12^, which is significantly greater than the dynamic quenching limit (10^10^), indicating a static quenching mechanism of CAT by SiO~2~ NPs ([Table 1](#T0001){ref-type="table"})[@CIT0003] Hence, it may be suggested that both dynamic and static quenching mechanisms are involved in the fluorescence quenching of CAT by SiO~2~ NPs.[@CIT0032],[@CIT0033]Table 1The *K~SV~* and *kq* values for the SiO~2~ NPs/CAT complex at three different temperaturesT*K~SV~* (M^−1^)*kq* (M^−1^ s^−1^)R^2^298(4.1±0.76)×10^4^(4.1±0.76)×10^12^0.92310(4.3±0.64)×10^4^(4.3±0.64)×10^12^0.91315(5.0±0.61)×10^4^(5.0±0.61)×10^12^0.95 Figure 2Stern--Volmer plots of CAT in the presence of different concentrations of SiO~2~ NPs at 298 (blue), 310 (orange) and 315 K (grey).

Binding parameters {#S0003-S2003}
------------------

[Figure 3](#F0003){ref-type="fig"} presents the variation of log(Fo-F/F) against log(\[SiO~2~ NPs\]) for CAT at 298, 310 and 315 K, calculated by using Equation (2)[@CIT0033] $$\documentclass[12pt]{minimal}
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\end{document}$$Figure 3Modified Hill plot of CAT in the presence of different concentrations of SiO~2~ NPs at 298 (blue), 310 (orange) and 315 K (grey).

It yields a linear plot with binding constant (log*K~b~*) of 2.28±0.32, 2.54±0.27 and 2.98±0.41 M^−1^ at 298, 310 and 315 K, respectively ([Table 2](#T0002){ref-type="table"}). It was also revealed that there is almost a half binding site (*n*) for SiO~2~ NPs in CAT. The half binding site suggests that two CAT molecules bind to one SiO~2~ NP.Table 2The n and log*K~b~* values for the SiO~2~ NPs/CAT complex at different temperaturesTnlog*K~b~* (M^−1^)R^2^2980.51±0.072.28±0.320.953100.55±0.082.54±0.270.953150.63±0.082.92±0.410.92

Thermodynamic parameters {#S0003-S2004}
------------------------

[Figure 4](#F0004){ref-type="fig"} exhibits the variation of Ln*K*~b~ against *1/T* at 298, 310 and 315 K, estimated by using van't Hoff Equation (3)[@CIT0034] $$\documentclass[12pt]{minimal}
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\end{document}$$Figure 4van't Hoff plot of CAT in the presence of SiO~2~ NPs at 298, 310 and 315 K.

It gives a slope which demonstrates the enthalpy change (∆*H*) with a value of 69.67 kJ/mol ([Table 3](#T0003){ref-type="table"}). The entropy change (*T*∆*S*) was estimated from the intercept to be 81.62±9.11, 84.90±10.28 and 86.27±13.35 kJ/mol at 298, 310 and 315 K, respectively. The positive signs of ∆*H* and ∆*S* demonstrate that hydrophobic forces are the main contributing interactions in the formation of the SiO~2~ NP/CAT complex[@CIT0035]Table 3The thermodynamic parameters of SiO~2~ NPs/CAT complex at three different temperaturesT∆*H* (kJ/mol)*T*∆*S* (kJ/mol)*∆G* (kJ/mol)29869.67±8.3481.62±9.11−11.95±1.8131069.67±8.3484.90±10.28−15.23±2.2931569.67±8.3486.27±13.35−16.60±2.41

Gibbs--Helmholtz [Equation (4)](#M0004) was used to calculate the Gibbs free energy (∆G)[@CIT0035] $$\documentclass[12pt]{minimal}
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The ∆G values were shown to be −11.95±1.81, −15.23±2.29 and −16.60±2.41 kJ/mol ([Table 3](#T0003){ref-type="table"}) at 298, 310 and 315 K, respectively. The negative sign of ∆G points to a spontaneous interaction between SiO~2~ NPs and CAT.

CD study {#S0003-S2005}
--------

CD is a potential technique usually employed for the detection of changes in secondary and tertiary conformation of protein.[@CIT0035],[@CIT0036] Backbone configuration of the protein is explored by the far-UV CD ellipticity changes within the range of 190--260 nm. In this range of wavelength, the secondary structure of the protein represents a characteristic magnitudewhich can be denatured or destabilized by triggering the structural alterations during the binding of NPs to the protein[@CIT0035] In order to explore the change in the secondary structure of CAT in the presence of varying concentrations of SiO~2~ NPs (5, 10 and 20 µm), far-UV CD spectra were measured ([Figure 5](#F0005){ref-type="fig"}). The CD spectrum of CAT demonstrates two characteristic negative peaks at 208 and 222 nm, indicating the alpha-helical configuration of CAT. Moreover, the CD spectra of CAT in the presence of varying concentrations of SiO~2~ NPs illustrate similar patterns, revealing the predominance of the α-helical structure even in the presence of high dose of SiO~2~ NPs. The α-helix content was not altered almost in the presence of SiO~2~ NPs, which depicts that the interaction between CAT and SiO~2~ NPs does not result in any significant change in the secondary structure of CAT. As deduced from [Figure 5](#F0005){ref-type="fig"}, the minimum positions and the ellipticity values of the CD spectra are not changed even after enhancing the molar ratio of NP, evincing that the native structure of CAT remains stable after the interaction[@CIT0035]Figure 5CD spectra of CAT in the presence of different concentrations of SiO~2~ NPs: 0 (black), 5 (red), 10 (blue) and 20 μM (green), at room temperature.

Activity assay {#S0003-S2006}
--------------

The influence of varying the concentration of SiO~2~ NPs (10--50 µM) on the CAT activity was explored. [Table 4](#T0004){ref-type="table"} summarizes the values of *Km, Vmax, Kcat* and the efficiency of CAT in the presence of different concentrations of SiO~2~ NPs. It can be observed that SiO~2~ NPs have not induced any significant effect on the CAT activity even at high concentrations. By increasing the concentration of SiO~2~ NPs, the kinetic parameters and efficiency of CAT were almost consistent. In fact, the efficacy of the enzyme was 7.1×10^7^ and 6.5×10^7^ min^−1^mM^−1^ in the absence and presence of 50 µM SiO~2~ NPs, respectively. This data manifests that the CAT efficiency dropped to only 8.5% relative to the native enzyme when the SiO~2~ NPs concentration increased to 50 µM, indicating that SiO~2~ NPs tend to keep the CAT protein in its native state with no significant denaturation.Table 4The kinetic parameters of CAT in the presence of varying concentrations of SiO~2~ NPs\[SiO~2~ NP\] (µM)*Km* (mM)*Vmax*(mM/min)*Kcat* (min^−1^)Efficiency (min^−1^mM^−1^)03.9±0.212.8±0.11×10^−1^2.8×10^8^7.1×10^7^103.9±0.192.8±0.25×10^−1^2.8×10^8^7.1×10^7^203.9±0.332.7±0.17×10^−1^2.7×10^8^6.9×10^7^504.0±0.392.6±0.28×10^−1^2.6×10^8^6.5×10^7^

Molecular docking {#S0003-S2007}
-----------------

At this stage, understanding the exact binding site of CAT is of crucial importance in order to understand the protein-NPs interaction. Administered or injected NPs may induce an affinity for the binding to the protein, formation of protein corona and results in the reduction of free fraction of the NPs. This binding affinity may play a pivotal role in the potential clinical consequence of NPs.

Molecular docking methods can predict the interaction between the protein and the NPs which have low or no similarity with real ligands. Accordingly, docking study can be used as a potential tool to define the binding affinity and the binding site of the protein that hosts the NPs. In the current study, the X-ray crystallographic structure of CAT was obtained from the protein data bank (1DGF) and molecular docking was carried out with NPs cluster as a ligand. The docked residues were visualized by using CHIMERA ([www.cgl.ucsf.edu/chimera](http://www.cgl.ucsf.edu/chimera)) and PyMOL (<http://pymol.sourceforge.net/>) graphical tools. The docked (SiO~2~)~72~/CAT and Si~20~/CAT systems are exhibited in [Figure 6](#F0006){ref-type="fig"}. The interacting residues of CAT with (SiO~2~)~72~ and Si~20~ clusters with a cutoff distance of 4 Å are shown in [Figures 7](#F0007){ref-type="fig"} and [8](#F0008){ref-type="fig"}, respectively. The nearest interacting residues for (SiO~2~)~72~/CAT are Met-394.B, Met-394.A, Pro-374.A, Tyr-379.A, Gln-395.B, Asp-396.B, Gly-400.B, Gly-399.B, Gln-395.B and Val-323.A. For Si~20~/CAT, the residues are Tyr-379.C, Pro-378.C, Cys-377.C, Ala-381.C, Arg-382.C, Val-383.C, Gln-395.C and Asp-396.C. This data suggests that hydrophobic residues are dominant amino acids in the binding pocket of CAT during the interaction with the NPs cluster. The calculated binding energies were found to be −519.95 and −248.30 E-value for (SiO~2~)~72~ and Si~20~ clusters, respectively. As a result, it can be suggested that CAT displays a higher affinity toward (SiO~2~)~72~ cluster than Si~20~ cluster.Figure 6The docked (SiO~2~)~72/~CAT (**A**) and Si~20~/CAT (**B**) systems.Figure 7The interacting residues of CAT with (SiO~2~)~72~ cluster from two different view angles.Figure 8The interacting residues of CAT with Si~20~ cluster from two different view angles.

Molecular dynamics simulation {#S0003-S2008}
-----------------------------

Molecular dynamics study can potentially complement the experimental data for the protein/NPs systems. The models of NPs and protein were covered by 500 water molecules and the annealing process was used to set the equilibrium temperatures at 298 K. The constant-energy, constant-volume ensemble with a time step of 1 fs, and a total simulation time of 200 ps were fixed in the simulations. [Figure 9](#F0009){ref-type="fig"} delineates the complex in the beginning of the simulation and after 200 ps. As can be seen, the SiO~2~ cluster causes partial unfolding of the CAT structure in the binding site over time. In fact, the α-helical structure of the protein remains almost intact after the interaction with SiO~2~ NPs. These results are in good agreement with CD spectroscopic results.Figure 9SiO~2~ cluster/CAT complex in the beginning and after 200 ps simulation.

MTT assay {#S0003-S2009}
---------

hMSCs cells were exposed to increasing concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) as detected by MTT assays ([Figure 10](#F0010){ref-type="fig"}). MTT data indicated a negligible cytotoxicity of SiO~2~ NPs against hMSCs up to 100 µg/mL. However, increasing the concentration of SiO~2~ NPs to 200 µg/mL causes a significant reduction (63.94±4.72) in the percent of viable cells after 24 hrs compared to the control sample (\**P*\<0.05) ([Figure 10](#F0010){ref-type="fig"}). The MTT assay demonstrates a dose-dependent cytotoxicity from which reliable data about the percentage of viable cells could be determined.Figure 10SiO~2~ NPs (up to 200 μg/mL) decrease the viability of hMSCs. The cells were incubated with varying concentrations of SiO~2~ NPs for 24 hrs before MTT assay was carried out. \**P*\<0.05 compared to the control group.

Cellular internalization of SiO~2~ NPs {#S0003-S2010}
--------------------------------------

The cytoplasmic internalization of SiO~2~ NPs by hMSCS was evaluated by flow cytometry analysis. A significant reduction in the fluorescent intensity of forward scatter (FSC) versus side scatter (SSC) subset ([Figure 11A](#F0011){ref-type="fig"} and B) was detected after hMSCs cells were incubated with 200 μg/mL of SiO~2~ NPs for 24 hrs. This is well established to be due to light reflection that derived from cellular NP internalization[@CIT0036] Indeed, the fold enhancement in SSC of hMSCs and fold reduction in FSC of hMSCs exposed to SiO~2~ NPs for 24 hrs reveal the cellular internalization of NPs.Figure 11Cellular internalization of SiO~2~ NPs into the hMSCs. (**A**) Control cells and (**B**) treated cells with SiO~2~ NPs (200 μg/mL).

Morphology of cells {#S0003-S2011}
-------------------

We also studied the morphological changes of hMSCs induced by different concentrations of SiO~2~ (0 [\[Figure 12A](#F0012){ref-type="fig"}\], 10 [\[Figure 12B](#F0012){ref-type="fig"}\], 50 [\[Figure 12C](#F0012){ref-type="fig"}\], 100 [\[Figure 12D](#F0012){ref-type="fig"}\] and 200 µg/mL [\[Figure 12E](#F0012){ref-type="fig"}\]). It was shown that morphological changes activated by increasing concentrations of SiO~2~ NP (1--100 μg/ml) were not obvious in hMSCs ([Figure 12A](#F0012){ref-type="fig"}--D). However, hMSCs have experienced a shrinkage in cytoplasm and roundness of the cells following exposure to 200 μg/mL of SiO~2~ NP ([Figure 12E](#F0012){ref-type="fig"}). This data suggests the occurrence of hMSCs morphological changes after exposure to high concentration of SiO~2~ NPs.Figure 12Morphological changes of hMSCs induced by different concentrations of SiO~2~ \[0 (**A**), 10 (**B**), 50 (**C**), 100 (**D**) and 200 µg/mL (**E**)\].

LDH assay {#S0003-S2012}
---------

After 24 hrs incubation of hMSCs with SiO~2~ NPs, LDH assay demonstrated a very low level of toxicity for all SiO~2~ NPs concentrations with membrane damage similar to the control samples ([Figure 13](#F0013){ref-type="fig"}). Indeed, LDH assay did not indicate a dose-dependent manner. The discrepancy between the MTT and the LDH assay data raised the probability that SiO~2~ NPs-induced cytotoxicity may occur through apoptosis rather than necrosis.Figure 13SiO~2~ NPs cause no increase in the level of LDH in cell culture medium. hMSCs cells were incubated with varying concentrations of SiO~2~ NPs for 24 hrs before examining the LDH activity of cell culture medium.

Production of ROS {#S0003-S2013}
-----------------

hMSCs cells exposed to different concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) for 24 hrs also revealed a significant increase in the production of ROS only at high concentrations (100 and 200 µg/mL), compared to the controls (\**P*\<0.05) ([Figure 14](#F0014){ref-type="fig"}). We observed that different concentrations of SiO~2~ NPs (1, 10, 50, 100 and 200 µg/mL) produced 116.33±17.07, 125.01±8.42, 136.66±24.05, 161.33±18.66 (\**P*\<0.05), 185.11±9.90 (\**P*\<0.05), respectively. While for the negative control group, the level of ROS was determined to be 114.66±6.54. On that account, the largest effect was observed for 100 and 200 µg/mL of SiO~2~ NPs as shown in [Figure 14](#F0014){ref-type="fig"}.Figure 14SiO~2~ NPs at concentrations of 100 and 200 μg/mL increase the level of ROS in hMSCs. hMSCs cells were incubated with SiO~2~ NPs for 24 hrs before the ROS level was examined. \**P*\<0.05 compared to control group.

Caspase-3 assay {#S0003-S2014}
---------------

Apoptotic stimuli including NPs result in apoptosis induction which is executed by the activation of caspases. Caspase-3 activation was assessed by colorimetric assay after 24 hrs, by measuring the absorbance change at 405 nm. [Figure 15](#F0015){ref-type="fig"} displays the results, where SiO~2~ NPs-induced activation of caspase-3 as an effector enzyme can only be observed at high concentration (200 µg/mL, \[\**P*\<0.05\]). Consequently, it is evident that all concentrations of SiO~2~ NPs did not cause activation of caspases, and the effect is most significant at high concentrations of SiO~2~ NPs.Figure 15SiO~2~ NPs at concentration of 200 μg/mL activate caspase-3 in hMSCs. hMSCs cells were incubated with varying concentrations of SiO~2~ NPs for 24 hrs before the caspase-3 activity was assessed. \**P*\<0.05 compared to control group.

Flow cytometry analysis {#S0003-S2015}
-----------------------

To further quantify cell apoptosis and necrosis, hMSCs were exposed to SiO~2~ NPs with a concentration of 200 μg/mL and then stained by employing Annexin V-FITC/PI double-staining method. The results are depicted in [Figure 16](#F0016){ref-type="fig"}, where A and B correspond to the representative plots of flow cytometry analysis in hMSCs in the absence and presence of SiO~2~ NPs (200 μg/mL), respectively. It can be seen from [Figure 16A](#F0016){ref-type="fig"} that almost no apoptotic or necrotic cells were discovered in negative control cells. Nevertheless, in the SiO~2~ NPs-treated sample, a significant increase in the population of apoptotic cells could be detected ([Figure 16B](#F0016){ref-type="fig"}). After 24 hrs of incubation with 200 μg/mL of SiO~2~ NPs, the percentage of hMSCs cells going through early-stage apoptosis was 8.45% (\*\**P*\<0.01), indicating apoptosis induction in the hMSCs cells. As expected, lower concentrations of SiO~2~ NPs did not induce any significant changes in the number of viable or apoptotic cells relative to the control cells (data not shown). These data confirm again that SiO~2~ NPs induce apoptosis in hMSCs only at high concentration.Figure 16hMSCs cells were incubated with 200 μg/mL of SiO~2~ NPs for 24 hrs, then co-stained with Annexin V-FITC/PI to quantify the apoptosis induction. (**A**) Control cells and (**B**) SiO~2~ NPs-treated cells.

Discussion {#S0004}
==========

Protein delivery[@CIT0037] or stem cell delivery[@CIT0002] can be used to treat several human disorders. For example, Scaletti et al[@CIT0038] revealed that NP-therapeutic protein supramolecular assemblies can be used to deliver therapeutic proteins into the cells. Cheng et al[@CIT0039] reported that metal-organic framework NPs can be applied as promising agents for protection and delivery of proteins. Zhang et al[@CIT0040] disclosed that NPs can be used as useful systems in stem cell delivery for treating some neurological disorders. Singhal et al[@CIT0041] reported that NP-mediated CAT delivery can mitigate the oxidative stress in human neurons. Song et al[@CIT0042] divulged that CAT‐loaded nanoshells can be used as bio‐nanoreactors and enzyme delivery carrier for increasing radiotherapy. Song et al[@CIT0043] showed that liposomes can be employed as excellent candidates for intracellular delivery of CAT. Li et al[@CIT0044] also suggested that some kind of nanosomes can be utilized as potential delivery and for increasing the bioactivity of CAT. In fact, as CAT delivery can be used to treat several diseases such as cancer therapy,[@CIT0045] ischemia/reperfusion,[@CIT0046] and vascular oxidative stress,[@CIT0047] the applications of NPs as efficient carriers can be used to deliver CAT to the target tissues. However, before application of NPs in delivery of therapeutic proteins or stem cells, the structure of proteins or cell viability should be evaluated in the presence of NPs. For these applications, the interaction of NPs with CAT should be investigated in order to explore the conformational changes and corresponding activity of CAT in the presence of NPs. In this paper, we demonstrated that SiO~2~ NPs did not significantly change the structure and activity of CAT. However, different studies have shown that multi-walled carbon nanotubes,[@CIT0048] TiO~2~ NPs,[@CIT0049] N-acetyl-L-cysteine-capped CdTe quantum dots,[@CIT0050] superparamagnetic iron oxide NPs[@CIT0051] and TiO~2~/WO~3~/GO nanocomposites[@CIT0012] caused substantial structural and functional alterations of CAT.

hMSCs are being widely used for cell therapy and as targeted therapeutic agents[@CIT0052] NPs can be used to develop a system including hMSCs-based cell engineering for tissue delivery[@CIT0004] It has been also demonstrated that NPs can be used as agents to track the stem cells[@CIT0053],[@CIT0054] and promote their differentiation.[@CIT0055],[@CIT0056] On that account, it also seems necessary to explore the cytotoxicity of NPs against hMSCs to introduce some promising NPs which can be implemented with hMSCs as promising agents for therapeutic purposes. In the current study, we unveiled that SiO~2~ NPs up to 100 µg/mL do not induce a remarkable cytotoxicity against hMSCs. In spite of that, Mancuso et al[@CIT0057] and Kim et al[@CIT0058] depicted that ZnO NPs induce mortality, morphological changes, cell cycle arrest and apoptosis in hMSC. Yan et al[@CIT0059] also revealed that the surface charge of carbon quantum dots can play an important role in the NP-induced cytotoxicity against hMSCs.

Therefore, it may be concluded that SiO~2~ NPs do not induce remarkable changes on the CAT activity and cytotoxicity against hMSCs. Future studies may involve functionalization of SiO~2~ NPs with different moieties and integrating with CAT in order to increase the activity of CAT and promote the differentiation of hMSCs for stem cell therapy in high oxidative stress regions. Indeed, CAT delivery by NPs can mitigate the oxidative stress and promote the efficacy of hMSCs in cell therapy.

Perspectives {#S0005}
============

Both the toxicity assay and therapeutic potency of NPs are critically urgent for their utilization in biomedical applications. For both plans, it is vital to explore some basic queries regarding how the biomolecules or cells contact with NPs. One question is to know the factors influencing the cellular effects of NPs. In the present study, we have mainly developed our information about the biological impacts of SiO~2~ NPs; however, comprehensive investigations about the mechanisms of toxicity of bare NPs and NPs/protein complex should be performed. The complexity in the characteristic of NPs, the kind of cells and proteins and even physicochemical features affect the biological system--NP interactions. It would be important to explore how these parameters influence the protein structures and cellular vitality. This brand new information will receive an advantage in the perceptive development of monohybrids in the time ahead. The second query is the methodological challenge as well as the type of biological systems as models in exploring NP-protein and NP-cell interactions. These challenges should be addressed by selecting the best models and appropriate techniques for understanding the NP-protein/cell interactions.

Well-established methods are necessary to disclose how NPs like SiO~2~ NPs affect conformations and viability of proteins and cells, respectively. It is crucial to use the proper techniques to speculate prospective adverse effects to protein and cells. Some biophysical techniques as well as bioinformatical investigations are potential to unveil some information regarding the protein structure incubated with NPs. Cellular assays will also help scientists to clarify signal pathways to explore the outcome from cell-NP interactions. The third query is how to reveal the interfacial interaction details among NPs, proteins and cells. This research may help to provide comprehensive affirmation regarding the chemical mechanisms for protein and cellular impacts of SiO~2~ NPs. By addressing these matters, we can acquire more exhaustive data regarding the interaction of NP with proteins or cells and this data will be useful for the reasoned development of potential and biocompatible nanovehicles in the future.

Conclusion {#S0006}
==========

CAT delivery by NPs may enhance the therapeutic efficacy of hMSCs by reducing the oxidative stress. However, NPs may induce some unwanted effects on the CAT structure and function and hMSCs viability. In this study, we explored the interaction of SiO~2~ NPs with CAT and hMSCs by different approaches. It was depicted that hydrophobic interactions are the main contributing forces in the spontaneous interaction of SiO~2~ NPs with CAT. Also, native structure and activity of CAT remain unchanged after interaction with SiO~2~ NPs. It was also demonstrated that SiO~2~ NPs triggered no remarkable cytotoxic effect against hMSCs till 100 µg/mL. Finally, SiO~2~ NP in combination with CAT as a multipotent complex may enable efficient cell therapy in future.
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